WallStSmart
HYPR

Hyperfine Inc

NASDAQ: HYPR · HEALTHCARE · MEDICAL DEVICES

$1.75
-8.00% today

Updated 2026-06-05

Market cap
$158.83M
P/E ratio
P/S ratio
10.36x
EPS (TTM)
$-0.40
Dividend yield
52W range
$1 – $2
Volume
0.7M

Hyperfine Inc (HYPR) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2019202020212022202320242025
Operating cash flow$-18.37M$-21.52M$-47.18M$-72.34M$-41.81M$-38.77M$-27.95M
Capital expenditures$244000.00$1.57M$2.71M$585000.00$804000.00$383000.00$1.19M
Depreciation
Stock-based comp$896000.00$1.12M$6.90M$10.65M$4.74M$4.36M$2.80M
Free cash flow$-18.62M$-23.09M$-49.89M$-72.92M$-42.61M$-39.15M$-29.13M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash$126.87M$-72.92M

Frequently asked questions

What is Hyperfine Inc's revenue?

Hyperfine Inc's trailing twelve-month revenue is $15.33M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is HYPR?

In its most recent fiscal year, HYPR ran a gross margin of 49.79%, an operating margin of -273.43%, and a net margin of -262.29%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does HYPR generate?

HYPR produced $-29.13M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is HYPR's balance sheet healthy?

HYPR holds $35.09M in cash and equivalents against — in long-term debt, on $41.01M of shareholder equity. That debt is best read against the cash flow the business throws off each year.